Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 0.83 |
| ▸ | TSHR | P16473 | 6/20 | 0.77 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.77 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.77 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.67 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.67 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.67 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.67 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.62 |
| ▸ | GABRP | O00591 | 1/20 | 0.62 |
| ▸ | GABRD | O14764 | 1/20 | 0.62 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.62 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.62 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutarate SCHEMBL7414 | 1.00 | — | — | |
| Glutarate SCHEMBL27601182 | 1.00 | SLC22A6 (1.00) | SLC22A6LMNATSHRNFKB1PMP22 | |
| Glutarate SCHEMBL6701735 | 1.00 | — | — | |
| Glutarate SCHEMBL106538 | 0.96 | SLC22A6 (0.92) | SLC22A6LMNATSHRNFKB1PMP22 | |
| Glutarate SCHEMBL5603986 | 0.96 | SLC22A6 (0.92) | SLC22A6LMNATSHRNFKB1PMP22 | |
| Glutarate SCHEMBL162952 | 0.96 | SLC22A6 (0.92) | SLC22A6LMNATSHRNFKB1PMP22 | |
| Glutarate SCHEMBL8618878 | 0.96 | SLC22A6 (0.92) | SLC22A6LMNATSHRNFKB1PMP22 | |
| Glutarate SCHEMBL20876932 | 0.96 | SLC22A6 (0.92) | SLC22A6LMNATSHRNFKB1PMP22 | |
| Glutarate SCHEMBL2067314 | 0.96 | SLC22A6 (0.92) | SLC22A6LMNATSHRNFKB1PMP22 | |
| Glutarate SCHEMBL9805513 | 0.96 | SLC22A6 (0.92) | SLC22A6LMNATSHRNFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108215366-A | Solventfree resin and preparation method thereof, reagent preparation box and application | 三星聚合物有限公司 | 2018-06-29 | — | — | CN | claimed |
| WO-2004089357-A2 | ANTI-FUNGAL FORMULATION OF TRITERPENE AND ESSENTIAL OIL | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2004-10-21 | — | — | WO | claimed |
| WO-2002026762-A1 | TRITERPENES HAVING ANTIBACTERIAL ACTIVITY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | claimed |
| CN-114269951-B | Diagnostic method for aesthetic deterioration of skin | 欧莱雅 | 2024-12-27 | — | — | CN | disclosed |
| CN-117143793-B | Method for producing 5-carbon compound or polymer thereof | 清华大学 | 2024-09-10 | — | — | CN | disclosed |
| WO-2023243349-A1 | BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHDO THEREFOR | 株式会社ダイセル | 2023-12-21 | — | — | WO | disclosed |
| CN-117143793-A | Method for producing 5-carbon compound or polymer thereof | 清华大学 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023181993-A1 | BIODEGRADABLE FLATTENED PARTICLES, COSMETIC COMPOSITION AND METHOD FOR PRODUCING BIODEGRADABLE FLATTENED PARTICLES | 株式会社ダイセル | 2023-09-28 | — | — | WO | disclosed |
| WO-2023119927-A1 | POROUS PARTICLE, COSMETIC COMPOSITION, AND PRODUCTION METHOD FOR POROUS PARTICLE | 株式会社ダイセル | 2023-06-29 | — | — | WO | disclosed |
| CN-114107156-B | Recombinant escherichia coli for efficiently producing glutaric acid, construction method and application thereof | 江南大学 | 2023-06-02 | — | — | CN | disclosed |
| US-20190214145-A1 | Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen | KUREK ITZHAK (US) | 2019-07-11 | — | — | US | disclosed |
| EP-1740930-A2 | SCREENING FOR SOLID FORMS BY ULTRASOUND CRYSTALLIZATION AND COCRYSTALLIZATION USING ULTRASOUND | S.S.C.I., Inc (US) | 2007-01-10 | — | — | EP | disclosed |
| US-7012155-B2 | Process for the production of carboxylic acids | LONZA S.P.A. (IT) | 2006-03-14 | — | — | US | disclosed |
| WO-2005089375-A2 | SCREENING FOR SOLID FORMS BY ULTRASOUND CRYSTALLIZATION AND COCRYSTALLIZATION USING ULTRASOUND | S.S.C.I., INC. (US) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005077377-A1 | COMPOSITIONS THAT INCLUDE A TRITERPENE AND A CARRIER | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-08-25 | — | — | WO | disclosed |
| WO-2004089357-A2 | ANTI-FUNGAL FORMULATION OF TRITERPENE AND ESSENTIAL OIL | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2004-10-21 | — | — | WO | disclosed |
| US-20030144549-A1 | Aliphatic carboxylic acids of formulae (Ib) R1-COOH(Ia) and R2- COOH wherein R1 is tertiary C4-20-alkyl and R2 is selected from hydrogen and C1-6-alkyl, or R1 and R2 together are -(CH2)n- with n=3 to 10, are produced by oxidizing an | LONZA S.P.A. (IT) | 2003-07-31 | — | — | US | disclosed |
| EP-0211042-A1 | LIPOSOME COMPOSITION AND METHOD | COOPER-LIPOTECH, INC. (US) | 1987-02-25 | — | — | EP | disclosed |
| WO-1986004232-A1 | LIPOSOME COMPOSITION AND METHOD | COOPER-LIPOTECH, INC. (US) | 1986-07-31 | — | — | WO | disclosed |
| US-4419507-A | BUTYLENE TEREPHTHALATE POLYMER | EASTMAN KODAK COMPANY (US) | 1983-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144549-A1 | Aliphatic carboxylic acids of formulae (Ib) R1-COOH(Ia) and R2- COOH wherein R1 is tertiary C4-20-alkyl and R2 is selected from hydrogen and C1-6-alkyl, or R1 and R2 together are -(CH2)n- with n=3 to 10, are produced by oxidizing an | ADIPOR1, AKR1C3, FASN | SLC22A6 786/4885LMNA 841/4885TSHR 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.